Latest

Enter the NR Times Awards 2026 now Parkinson’s vaccine shows promise in clinical trial Brain-computer interface firm raises $250m for US rollout Smart shoe could monitor gait in TBI, Parkinson’s and more Can meaningful changes still occur 10 Years after spinal cord injury?Mood swings, brain fog, fatigue… Is it brain injury, the menopause or both?Nurse discovers renewed sense of purpose in neuropsychiatric rehabilitation Brain injury charities to benefit from golf fundraise Tetraplegic veteran completes 79-mile challenge for spinal injury charity 26-year-old boxer dies a week after suffering brain bleed Introducing the Immersive BPM Project (iBPM)Enter the NR Times Awards 2026 now Parkinson’s vaccine shows promise in clinical trial Brain-computer interface firm raises $250m for US rollout Smart shoe could monitor gait in TBI, Parkinson’s and more Can meaningful changes still occur 10 Years after spinal cord injury?Mood swings, brain fog, fatigue… Is it brain injury, the menopause or both?Nurse discovers renewed sense of purpose in neuropsychiatric rehabilitation Brain injury charities to benefit from golf fundraise Tetraplegic veteran completes 79-mile challenge for spinal injury charity 26-year-old boxer dies a week after suffering brain bleed Introducing the Immersive BPM Project (iBPM)

Wednesday 30 September

Condition ›

Huntington’s

Huntington’s disease care and research.

Brain injury Spinal injury Stroke Concussion Parkinson's Multiple sclerosis MND / ALS Dementia Long COVID

Huntington's28 Oct
New Huntington’s disease discovery could pave the way for treatments
Researchers have identified a key biochemical mechanism relevant to the development of Huntington’s Disease that opens the possibility of studying the disease before its clinical onset and eventually stopping its progression. The study has shown for the first time the biochemical change responsible for the development of Huntington’s disease, and how blocking this change stopped [...]
Huntington's3 Oct
Firm targeting Huntington’s drug secures £35m funds
A biotech firm which is aiming to slow down the neurodegeneration process in Huntington's has completed a £35m funding round to support is drug development work. LoQus23 Therapeutics is investigating small molecule drugs that could stop DNA instability and slow disease progression in Huntington's Disease, as well as myotonic dystrophy type 1 and similar triplet [...]

Previous 1···34